Precious Metals

[gfp927z]

>>> Moleculin Announces Conference Call to Discuss Significant Discovery For Lung Cancer and FDA Activity on Wednesday, April 24, 2019


April 22, 2019

https://ir.moleculin.com/press-releases/detail/130/moleculin-announces-conference-call-to-discuss-significant


HOUSTON, April 22, 2019 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors, today announced it will host a conference call to discuss its significant discovery for lung cancer, FDA Fast Track Designation and recent corporate events. The call will be at 4:30 p.m. ET on Wednesday, April 24, 2019.

Participants can dial [phone] or [phone] to access the conference call, or can listen via a live webcast, which is available in the Investor Relations section of the Company's website at www.moleculin.com. The Company will field live questions from equity analysts in a Q&A segment of this call. Participants may submit questions in advance for the Company to address in the Q&A segment by sending them to [e-mail]. A webcast replay will be available in the Investors section of the Company's website at www.moleculin.com for 90 days. A teleconference replay will be available at [phone] or [phone], confirmation code 10130980, through May 1, 2019.

<<<